Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, July 26, 2024.
GT Biopharma, Inc. (NASDAQ:GTBP)
Long-Term Downtrend (-90) - GTBP is in a strong downtrend that is likely to continue. While GTBP is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid GTBP?
MarketClub looks at technical strength and momentum to determine if the timing is right for GTBP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for GTBP
The long-term trend has been DOWN since Jun 10th, 2024 at 2.9539
The intermediate-term trend has been DOWN since Jun 10th, 2024 at 3.1200
The short-term trend has been DOWN since Jul 22nd, 2024 at 2.7000
Smart Scan Analysis for GTBP
Based on our trend formula, GTBP is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 2.760 | 2.795 | 2.720 | 2.790 | +0.030 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.760 | 1648 | 2024-07-26 13:50:44 |
| Year High | 5.85 | Year High Date | 2018-01-10 |
| Year Low | 0.61 | Year Low Date | 2018-11-14 |
| 52wk High | 10.6599 | 52wk High Date | 2024-05-20 |
| 52wk Low | 2.6 | 52wk Low Date | 2024-06-27 |
| Average Volume | 51,458 | Shares Outstanding | 1,417 |
| Assets | 9,912,000M | Liabilities | 4,600,000M |
| P/E Ratio | -0.54110000 | Volatility | 218 |